http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2668457-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee814b1ba7fddffa2ecdea48bf074f4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1875
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0455ba3717facc63558cdc854865385
publicationDate 2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2668457-A1
titleOfInvention Imaging of activated vascular endothelium using immunomagnetic mri contrast agents
abstract lmmunomagnetic nanoparticles are used as a contrast agent for enhancing medical diagnostic imaging such as magnetic resonance imaging (MRI). The present invention is directed to methods of making targeted MRI contrast agents from immunomagnetic particles, and to methods of using such MRI contrast agents. Typically, such targeted MRI contrast agents provide enhanced relaxivity, improved signal-to-noise, targeting ability, and resistance to agglomeration. Methods of making such MRI contrast agents typically afford better control over particle size, and methods of using such MRI contrast agents typically can afford enhanced blood clearance rates and distribution. The ability to use the contrast agents im MRI provides a tool in the diagnosis and treatment of several disease states.
priorityDate 2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453759058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450360487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15894
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25464
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24838310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454118689
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450540594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432052

Total number of triples: 29.